Latest news with #Specialty
&w=3840&q=100)
Business Standard
23-05-2025
- Business
- Business Standard
Sun Pharma share price slips 5% after Q4 results; check key numbers here
Sun Pharma share price: Pharmaceutical company Sun pharma shares were under pressure on Friday, May 23, 2025, with the scrip dropping up to 4.86 per cent lower to an intraday low of ₹1,636.30 per share. By 9:24 AM, Sun Pharma shares continued to trade near day's low level, down 4.66 per cent lower at ₹1,639.90 per share. In comparison, BSE Sensex was trading 0.08 per cent higher at 81,015.07 level. Why did Sun Pharma share price drop in trade? Sun Pharma share price dropped after the company posted a mixed bag of results in the March quarter of financial year 2025 (Q4FY25). The company's net profit dropped 19 per cent year-on-year (Y-o-Y) to ₹2,153.9 crore in the March quarter of financial year 2025 (Q4FY25), from ₹2,658.74 crore in the same quarter last year (Q4FY24). Revenue from operations, however, increased 8.49 per cent Y-o-Y to ₹12,815.58 crore, up from ₹11,813.33 crore in Q4FY24. Sun Pharma dividend Sun Pharma's board has recommended a final dividend of ₹5.5 per equity share of face value ₹1 each, subject to shareholders' approval at the upcoming Annual General Meeting. The company has fixed Monday, July 7, 2025 as Record Date for the purpose of determining the Members eligible to receive the final dividend. "Our businesses delivered a robust performance for the year, driven by improving market share in India and growth in Global Specialty. The nearterm pipeline in Global Specialty is promising, with products such as Leqselvi and Unloxcyt—the latter through our recently announced Checkpoint acquisition—offering significant improvements in patient care. We look forward to Specialty becoming an increasingly important part of our business," said Dilip Shanghvi, chairman and managing director, Sun Pharma. About Sun Pharma Founded in 1983, Sun Pharmaceutical Industries is the world's fourth-largest specialty generic pharmaceutical company, with global revenues of $5.8 billion. With a presence in over 100 countries and 41 manufacturing facilities worldwide, Sun Pharma delivers high-quality, affordable medicines trusted by healthcare professionals and patients alike. Its diverse portfolio includes over 2,000 high-quality molecules across generics, branded generics, specialty and complex products, OTC, ARVs, APIs, and intermediates—spanning multiple dosage forms such as tablets, capsules, injectables, inhalers, and topical formulations. The company is ranked among the top generic pharmaceutical firms in the US, especially in the dermatology space, and maintains a strong presence across key emerging markets like Brazil, Mexico, Russia, and South Africa. The company consistently invests 6–8 per cent of its global revenues in R&D, supported by a team of over 3,000 scientists, driving innovation in areas like liposomal formulations, lyophilised injections, and controlled-release systems.
Yahoo
18-02-2025
- Health
- Yahoo
The ONS and Chamberlain University Collaborate to Offer Oncology Nursing Practice Ready. Specialty Focused. ™ Course
Chamberlain University and the Oncology Nursing Society launched the Oncology Nursing PRSF Course, an in-depth curriculum that equips students with the skills, knowledge, and preparation needed to pursue oncology nursing. CHICAGO, February 18, 2025--(BUSINESS WIRE)--The Oncology Nursing Society (ONS) and Adtalem Global Education have partnered to offer Chamberlain University nursing students a free course that provides an in-depth introduction to oncology nursing. The class is a part of the institution's Practice Ready. Specialty Focused. ™ (PRSF) initiative, which acquaints pre-licensure students with the various healthcare specialties available through hands-on experiences with practicing nurses. Funded by a grant from the American Nurses Foundation, the PRSF program is part of Adtalem's dedicated efforts to address the country's ongoing nursing shortage. "As an Executive Dean at Chamberlain and a former oncology and hospice nurse, I can attest to the deeply rewarding nature of this field," said Chamberlain University Executive Dean, MSN/RN-BSN Programs Rhoda Murray, Ph.D., FNP-C. "I wish that, as a young nurse, I had access to a specialized course like this so I could have been better prepared earlier in my career to provide exceptional care, compassionate support, and hope during the most challenging times in the lives of patients and their families." ONS and Chamberlain University collaborated to develop a 16-week Introduction to Oncology Nursing class, available online and at all 23 Chamberlain campuses. The class provides students with a foundation for providing care to patients experiencing a cancer diagnosis, treatment complications, or trouble coping. The course contains four modules—Cancer Basics, Cancer Treatment Modalities, Symptom Management, and Cancer Treatment and Beyond—each lasting four weeks. "ONS is pleased to partner with Chamberlain University to introduce students to the rewarding field of oncology nursing early in their education," said ONS Chief Executive Officer Brenda Nevidjon, MSN, RN, FAAN. "By offering a dedicated oncology nursing curriculum, we aim to inspire interest in this vital specialty and prepare future nurses, helping to address the growing demand for nurses in cancer care." Along with oncology, additional PRSF courses offered at Chamberlain University campuses and online include emergency nursing, perioperative, home health nursing, nephrology, and critical care nursing. From January 2022 through May 2024, 2,263 students enrolled in the PRSF online 16-week courses with an over 90 percent completion rate. About the Oncology Nursing Society ONS is a professional association that represents 100,000 oncology nurses and is the professional home to more than 35,000 members. ONS is committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all to improve quality of life and outcomes for patients with cancer and their families. Learn more at About Chamberlain University Chamberlain University, an Adtalem Global Education (NYSE: ATGE) institution, educates, empowers, and emboldens a diverse community of healthcare professionals who seek to advance the health of people, families, communities, and nations. Chamberlain has the largest school of nursing in the U.S., with both on-campus and online degree programs. Chamberlain is comprised of the College of Nursing and the College of Health Professions, offering a variety of bachelor's, master's, doctoral, and certificate programs. Chamberlain University is accredited by the Higher Learning Commission. Visit for more information, and follow on Twitter, Instagram, Facebook, and LinkedIn. About Adtalem Global Education Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a diverse workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and inclusivity is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 350,000 alumni and nearly 10,000 dedicated employees. Visit for more information and follow us on LinkedIn , Instagram and Facebook. View source version on Contacts Media Contact: Jason Carr773-858-7932adtalemmedia@ ONS Press Contact: Molly ColvilleDirector of Marketing412.859.6146mcolville@ Sign in to access your portfolio
